476 related articles for article (PubMed ID: 23020522)
1. Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury.
Devarbhavi H; Singh R; Patil M; Sheth K; Adarsh CK; Balaraju G
J Gastroenterol Hepatol; 2013 Jan; 28(1):161-7. PubMed ID: 23020522
[TBL] [Abstract][Full Text] [Related]
2. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
[TBL] [Abstract][Full Text] [Related]
3. The Indian Network of Drug-Induced Liver Injury: Etiology, Clinical Features, Outcome and Prognostic Markers in 1288 Patients.
Devarbhavi H; Joseph T; Sunil Kumar N; Rathi C; Thomas V; Prasad Singh S; Sawant P; Goel A; Eapen CE; Rai P; Arora A; Leelakrishnan V; Gopalakrishnan G; Vardhan Reddy V; Singh R; Goswami B; Venkataraman J; Balaraju G; Patil M; Patel R; Taneja S; Koshy A; Nagaraja Rao P; Kumar Sarin S; Rathi P; Dhiman R; Duseja AK; Vargese J; Kumar Jain A; Wadhawan M; Ranjan P; Karanth D; Ganesh P; Nijhawan S; Krishna Dhali G; Adarsh CK; Jhaveri A; Nagral A; Rao P; Shalimar
J Clin Exp Hepatol; 2021; 11(3):288-298. PubMed ID: 33994711
[TBL] [Abstract][Full Text] [Related]
4. Antituberculous drug-induced liver injury: current perspective.
Devarbhavi H
Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.
Devarbhavi H; Patil M; Reddy VV; Singh R; Joseph T; Ganga D
Liver Int; 2018 Jul; 38(7):1322-1329. PubMed ID: 29222960
[TBL] [Abstract][Full Text] [Related]
6. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury.
Jeong R; Lee YS; Sohn C; Jeon J; Ahn S; Lim KS
Scand J Gastroenterol; 2015 Apr; 50(4):439-46. PubMed ID: 25639449
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
[TBL] [Abstract][Full Text] [Related]
9. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
10. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
[TBL] [Abstract][Full Text] [Related]
11. [Drug-induced liver injury as predominant cause of acute liver failure in a monocenter study].
Bechmann LP; Manka P; Best J; Saner FH; Paul A; Canbay A; Gerken G
Dtsch Med Wochenschr; 2014 May; 139(17):878-82. PubMed ID: 24760689
[TBL] [Abstract][Full Text] [Related]
12. Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality.
Rathi C; Pipaliya N; Patel R; Ingle M; Phadke A; Sawant P
Ann Hepatol; 2017; 16(3):442-450. PubMed ID: 28425415
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of protionamide and para-aminosalicylic acid induced hepatotoxicity in 129 cases].
Ge QP; Wang QF; Duan HF; Wang J; Chu NH
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):737-40. PubMed ID: 24433800
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
Baekdal M; Ytting H; Skalshøi Kjær M
Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus infection: clinical implications in tuberculosis treatment.
Trigo C; do Brasil PE; Costa MJ; de Castro L
J Viral Hepat; 2016 Dec; 23(12):1027-1035. PubMed ID: 27624908
[TBL] [Abstract][Full Text] [Related]
17. An official ATS statement: hepatotoxicity of antituberculosis therapy.
Saukkonen JJ; Cohn DL; Jasmer RM; Schenker S; Jereb JA; Nolan CM; Peloquin CA; Gordin FM; Nunes D; Strader DB; Bernardo J; Venkataramanan R; Sterling TR;
Am J Respir Crit Care Med; 2006 Oct; 174(8):935-52. PubMed ID: 17021358
[TBL] [Abstract][Full Text] [Related]
18. Drug-Induced Liver Injury from Anti-Tuberculosis Treatment: A Retrospective Cohort Study.
Zhao H; Wang Y; Zhang T; Wang Q; Xie W
Med Sci Monit; 2020 Mar; 26():e920350. PubMed ID: 32145061
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of TB/HIV co-infected patients presenting with antituberculosis drug-induced liver injury.
Naidoo S; Evans D; Jong E; Mellet K; Berhanu R
S Afr Med J; 2015 Apr; 105(5):393-6. PubMed ID: 26242667
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in ethiopian patients.
Yimer G; Gry M; Amogne W; Makonnen E; Habtewold A; Petros Z; Aderaye G; Schuppe-Koistinen I; Lindquist L; Aklillu E
PLoS One; 2014; 9(4):e94271. PubMed ID: 24714066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
